COURAGE-ALS: a Randomized, Double-Blind Phase 3 Study Designed to Improve Participant Experience and Increase the Probability of Success
Jeremy M. Shefner,Ammar Al-Chalabi,Jinsy A. Andrews,Adriano Chio,Mamede De Carvalho,Bettina M. Cockroft,Philippe Corcia,Philippe Couratier,Merit E. Cudkowicz,Angela Genge,Orla Hardiman,Terry Heiman-Patterson,Robert D. Henderson,Caroline Ingre,Carlayne E. Jackson,Wendy Johnston,Noah Lechtzin,Albert Ludolph,Nicholas J. Maragakis,Timothy M. Miller,Jesus S. Mora Pardina,Susanne Petri,Zachary Simmons,Leonard H. Van Den Berg,Lorne Zinman,Stuart Kupfer,Fady I. Malik,Lisa Meng, Tyrell J. Simkins,Jenny Wei, Andrew A. Wolff,Stacy A. Rudnicki AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION（2023）
关键词
Amyotrophic lateral sclerosis,randomized clinical trial,reldesemtiv,ALSFRS-R
AI 理解论文
溯源树
样例
